The program is still filling in: the organizers list three tracks as under development and many talk titles as to be confirmed. We’ll add new sessions and the organizations presenting them as the agenda grows.

Infectious disease and AMR at World Vaccine Congress 2027

Mar 8–11, 2027 Washington, DC ~3k attendees Website

56 organizations at World Vaccine Congress 2027 present work in infectious disease & AMR: 16 vaccine and drug developers, 16 academic bodies, 12 public-health and non-profit bodies and 12 suppliers and service providers. Between them they bring 54 presentations to the program. Most represented: Sanofi, Pfizer and Boston Children's Hospital. As of Oct 8, 2026.

All 222 organizations at World Vaccine Congress 2027 →

Showing 1–15 of 56 organizations

Organization	World Vaccine Congress 2027 Attendance
Sanofi Paris, France
sanofi.com Large pharmaBronze sponsor Global pharmaceutical company with a large vaccines business spanning influenza, pediatric, meningitis and mRNA programs.	Booth Exhibiting (no floor booth listed) Chair Wed Mar 10 09:00 Chair’s opening remarks Influenza & Respiratory Diseases Track Panel Wed Mar 10 09:10 Panel: Pharma Ready: What It Really Takes to Seal the Deal What large drug companies look for before partnering with a young vaccine company, from manufacturing readiness and patents to timing the conversation. with Omniose, Vaxcyte, Eli Lilly Talk Wed Mar 10 15:40 Sanofi Respiratory Vaccine Pipeline Updates Influenza & Respiratory Diseases Track
Pfizer New York, NY
pfizer.com Large pharma Global pharmaceutical company with a vaccine portfolio spanning pneumococcal, RSV, COVID-19 and other infectious diseases.	Keynote Tue Mar 9 14:55 The Longevity Dividend: Scaling Adult Immunization for an Aging Global Population How vaccines for older adults can overcome age-related immune decline and a crowded adult schedule, and how to raise low uptake worldwide. with Africa CDC Clinical & preclinical developmentSupply, safety & access Talk Wed Mar 10 15:10 Pfizer Respiratory Vaccine Pipeline Updates Influenza & Respiratory Diseases Track Talk Wed Mar 10 16:40 Strategies for large scale vaccinations for the world – multidose vial and CMC challenges Bioprocessing & Manufacturing Track
Boston Children's Hospital Boston, MA
childrenshospital.org Academic Pediatric teaching hospital of Harvard Medical School, home to the Precision Vaccines Program.	Talk Mon Mar 8 10:00 Vaccine Technology Workshop New vaccine technologies, from machine learning that pairs adjuvants with antigens to self-amplifying RNA and a liposome-adjuvanted malaria vaccine. with Montani Biotechnologies, Arcturus Therapeutics, Akagera Medicines +2 more Talk Wed Mar 10 09:10 Vaccine Safety Track: sessions to be announced with Johns Hopkins Bloomberg School of Public Health, Brighton Collaboration, Global Vaccine Data Network +1 more Talk Thu Mar 11 09:10 The Vanguard of Preparedness: Using Humanized In Vitro Systems to Predict Neonatal and Pediatric Immunogenicity for Outbreak Pathogens Pandemic Platforms Track
University of Pennsylvania Philadelphia, PA
upenn.edu Academic Research university whose Perelman School of Medicine pioneered the modified mRNA used in COVID-19 vaccines.	Talk Mon Mar 8 10:00 AMR Workshop How vaccines, antibodies and phage therapy can be developed, funded and used against drug-resistant bacteria, from infant infections to livestock. with Omniose, AMR Strategic Coalition, Gates Foundation +6 more Talk Wed Mar 10 12:30 The Exemption Expansion: Mandate Trends Under Trump II Vaccine Access Track Talk Thu Mar 11 09:40 Protective Pan-Betacoronavirus Neutralizing Antibodies by Vaccination Pandemic Platforms Track
Eli Lilly Indianapolis, IN
lilly.com Large pharma Global pharmaceutical company whose medicines span diabetes, obesity, oncology, immunology and neuroscience, with antibody research against infectious diseases.	Talk Mon Mar 8 10:00 Antibodies for Infectious Diseases Workshop Research on antibody medicines that treat or prevent infectious diseases. with AstraZeneca, ModeX Therapeutics, GigaGen Panel Wed Mar 10 09:10 Panel: Pharma Ready: What It Really Takes to Seal the Deal What large drug companies look for before partnering with a young vaccine company, from manufacturing readiness and patents to timing the conversation. with Omniose, Vaxcyte, Sanofi
International Vaccine Institute Seoul, South Korea
ivi.int Public health & non-profit International non-profit organization developing and delivering vaccines for global health.	Keynote Tue Mar 9 09:30 Keynote Panel: Are We Ready for the Next Outbreak? Reconciling Surveillance, Diagnostics, and the MCM Pipeline How surveillance, diagnostics and regulators can work together to get vaccines deployed quickly in sudden outbreaks of viruses like Ebola and Marburg. with ACEGID, PATH, Africa CDC Infectious disease & AMR
Callen-Lorde New York, NY
callen-lorde.org Academic Community health center providing primary care and sexual health services to LGBTQ communities in New York City.	Talk Mon Mar 8 10:00 HIV Vaccines Workshop Where the search for an HIV vaccine stands, from laboratory advances and ongoing clinical trials to plans for fair global access. with Fred Hutch, IAVI, ModeX Therapeutics Keynote Thu Mar 11 14:20 Closing Keynote: Reimagining public health infrastructure in the USA – opportunities to rebuild with intention How the US could rebuild its public health system for the long term, from disease forecasting and biodefense to universal vaccine access. with Infectious Diseases Society of America, Manatt Health Supply, safety & access
National University of San Martín San Martín, Argentina
unsam.edu.ar Academic Argentine public university whose researchers developed ARVAC, a recombinant protein COVID-19 vaccine.	Talk Wed Mar 10 12:25 Phase IV results of the ARVAC vaccine, the first COVID-19 vaccine approved in South America and endorsed by PAHO Pandemic Platforms Track Talk Wed Mar 10 12:40 Immune Responses Induced by the ARVAC Booster Vaccine Following Phase IV Evaluation Immune Profiling Track
Americas Health Foundation Washington, DC
americashealthfoundation.org Public health & non-profit Nonprofit that convenes experts to produce evidence and policy recommendations to widen healthcare access in Latin America.	Talk Mon Mar 8 10:00 Global Health Workshop How to move vaccines for poorer countries past long-standing roadblocks in development, and what shapes fair access in low-resource settings. with London School of Hygiene & Tropical Medicine, Think Vaccines, Gavi, the Vaccine Alliance +2 more Supply, safety & accessInfectious disease & AMR
AstraZeneca Cambridge, United Kingdom
astrazeneca.com Large pharma Global pharmaceutical company whose vaccines and immune therapies unit develops antibodies and vaccines against respiratory and other infections.	Talk Mon Mar 8 10:00 Antibodies for Infectious Diseases Workshop Research on antibody medicines that treat or prevent infectious diseases. with ModeX Therapeutics, Eli Lilly, GigaGen
Baylor College of Medicine Houston, TX
bcm.edu Academic Medical school whose Texas Children's Hospital Center for Vaccine Development develops low-cost vaccines for neglected and emerging diseases.	Talk Mon Mar 8 10:00 Global Health Workshop How to move vaccines for poorer countries past long-standing roadblocks in development, and what shapes fair access in low-resource settings. with London School of Hygiene & Tropical Medicine, Think Vaccines, Gavi, the Vaccine Alliance +2 more Supply, safety & accessInfectious disease & AMR
Gavi, the Vaccine Alliance Geneva, Switzerland
gavi.org Public health & non-profit Global vaccine alliance funding immunization and shaping vaccine markets for lower-income countries.	Talk Mon Mar 8 10:00 Global Health Workshop How to move vaccines for poorer countries past long-standing roadblocks in development, and what shapes fair access in low-resource settings. with London School of Hygiene & Tropical Medicine, Think Vaccines, Americas Health Foundation +2 more Supply, safety & accessInfectious disease & AMR
GPN Vaccines
gpnvaccines.com Biotech Biotech developing next-generation broad-spectrum vaccines, with candidates in clinical trials.	Talk Mon Mar 8 10:00 AMR Workshop How vaccines, antibodies and phage therapy can be developed, funded and used against drug-resistant bacteria, from infant infections to livestock. with Omniose, AMR Strategic Coalition, Gates Foundation +6 more
PATH Seattle, WA
path.org Public health & non-profit Global health non-profit working on vaccine development, delivery and immunization systems in low- and middle-income countries.	Keynote Tue Mar 9 09:30 Keynote Panel: Are We Ready for the Next Outbreak? Reconciling Surveillance, Diagnostics, and the MCM Pipeline How surveillance, diagnostics and regulators can work together to get vaccines deployed quickly in sudden outbreaks of viruses like Ebola and Marburg. with ACEGID, Africa CDC, International Vaccine Institute Infectious disease & AMR
Vaccine Formulation Institute
vaccineformulationinstitute.org Public health & non-profit Swiss centre of expertise in adjuvants and vaccine formulation that develops adjuvants and supplies them at GMP grade under open-access terms.	Talk Mon Mar 8 10:00 Global Health Workshop How to move vaccines for poorer countries past long-standing roadblocks in development, and what shapes fair access in low-resource settings. with London School of Hygiene & Tropical Medicine, Think Vaccines, Gavi, the Vaccine Alliance +2 more Supply, safety & accessInfectious disease & AMR